Related Experiment Video
Updated: Jul 9, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Identification of p32 as a novel substrate for ATM in heart
Hisakazu Kato1, Seiji Takashima, Yoshihiro Asano
1Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
Chemotherapeutic agents to induce DNA damage have been limited to use due to severe side effects of cardiotoxicity. ATM (Ataxia-telangiectasia mutated) is an essential protein kinase in triggering DNA damage responses. However, it is unclear how the ATM-mediated DNA damage responses are involved in the cardiac cell damage. To elucidate these functions in heart, we searched for specific substrates of ATM from mouse heart homogenate. Combining an in vitro phosphorylation following anion-exchange chromatography with purification by reverse-phase high-performance liquid chromatography (HPLC), we successfully identified p32, an ASF/SF2-associated protein, as a novel substrate for ATM. An in vitro kinase assay using recombinant p32 revealed that ATM directly phosphorylated p32. Furthermore, we determined Ser 148 of p32 as an ATM phosphorylation site. Since p32 is known to regulate mRNA splicing and transcription, p32 phosphorylation by ATM might be a new transcriptional regulatory pathway for specific DNA damage responses in heart.
Insights
Researchers identified p32 as a novel ATM substrate in the heart, revealing a new pathway for DNA damage response that may impact cardiotoxicity from chemotherapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Chemotherapy-induced DNA damage can cause cardiotoxicity, limiting treatment efficacy.
- ATM (Ataxia-telangiectasia mutated) is crucial for DNA damage response but its role in cardiac cells is unclear.
- Understanding ATM's cardiac function is vital for mitigating chemotherapy side effects.
Purpose of the Study:
- To identify ATM substrates in mouse heart homogenate.
- To elucidate the role of ATM-mediated DNA damage response in cardiac cells.
- To investigate potential new pathways for cardiac protection during chemotherapy.
Main Methods:
- In vitro ATM kinase assays using purified recombinant proteins.
- Anion-exchange chromatography and reverse-phase HPLC for protein purification.
- Identification of ATM substrates through phosphorylation analysis.
Main Results:
- p32, an ASF/SF2-associated protein, was identified as a novel substrate of ATM in mouse heart.
- ATM directly phosphorylates p32 in vitro.
- Serine 148 (Ser 148) was identified as the specific ATM phosphorylation site on p32.
Conclusions:
- ATM directly phosphorylates p32 at Ser 148 in cardiac cells.
- This phosphorylation may represent a novel regulatory pathway for DNA damage response in the heart.
- Further research into this pathway could lead to strategies for reducing chemotherapy-induced cardiotoxicity.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
cAMP-dependent Protein Kinase Pathways

